• <button id="wqt97"><object id="wqt97"></object></button>
    1. <rp id="wqt97"></rp>
      

        <em id="wqt97"><object id="wqt97"><input id="wqt97"></input></object></em>

        BRL Medicine's new generation of universal CAR-T therapy has been approved by domestic IND

        MORE

        BRL Medicine World's first non viral PD1 fixed-point integration CAR-T product

        MORE

        World’s first clinical trial of non-viral PD1 specific targeted CART therapy achieves great breakthroughs

        MORE

        Lead the world! BRL Medicine's new generation of Quikin CAR-T research results published in Nature

        MORE

        BRL Medicine published in Nature Medicine that BRL-101 gene therapy for children with thalassemia has been free of transfusion dependence for more than 2 years

        MORE

        About BRL Medicine

        At BRL Medicine Inc., we aim to become the world's leading Cellular & Gene pharmaceutical company in the era of new commercial civilization, with the mission of?"Through innovation led by gene editing, develop breakthrough human therapeutics and benefit the whole world". With its independent R&D center and the "Shanghai Research Center for Gene Editing and Cell Therapy", jointly established by?BRL Medicine and university,?BRL Medicine?has obtained more than 100 patent achievements, and initiated 5 Investigator-Initiated clinical Trials (IIT) in 8 leading hospitals in China, with many pipeline projects have entered into IND application stage.?

        Learn More

        Gene Therapy

        The world's first CRISPR gene editing
        treatment of β0/β0 type thalassemia is successful

        LEARN MORE

        Cell Therapy

        World's first clinical trial of non-viral PD1
        specific targeted CART therapy achieves great breakthroughs

        LEARN MORE

        Product Pipeline

        Subscribe:Submit
        Back to top
        亚洲国产精品不卡毛片a在线,国产午夜毛片v一区二区三区,亚洲欧洲另类春色校园网站,欧美性猛交xxxx免费看,久久国产欧美日韩精品,日韩亚洲精品不卡在线,亚洲欧美另类中文字幕,国产精品国产三级国产在线观看